Sunday, September 24, 2023
Read Overview
Supported by independent educational grants from CTI Biopharma; GlaxoSmithKline; Incyte; Janssen; Regeneron; Seagen, Inc.
Steering Committee Chair
Chair and Professor
Department of Hematology and Medical Oncology
Chief Medical Officer
Winship Cancer Institute of Emory University
Atlanta, Georgia
Steering Committee Member
Associate Professor
Department of Leukemia
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Steering Committee Member
Chair, Professor
Department of Lymphoma/Myeloma
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Steering Committee Member
Associate Attending Physician
Department of Medicine
Lymphoma Service
Memorial Sloan Kettering Cancer Center
New York, New York
Steering Committee Member
Professor
Department of Leukemia
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Steering Committee Member
Professor of Medicine
Division of Hematology
Department of Internal Medicine
Mayo Clinic
Rochester, Minnesota
Steering Committee Member
Assistant Professor of Clinical Medicine
Adjunct Clinical Assistant Professor of Nursing
University of Arizona
Tucson, Arizona
Steering Committee Member
Clinical Pharmacy Specialist
Emory Healthcare
Atlanta, Georgia
Steering Committee Chair
The opinions expressed are those of Dr Lonial and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Lonial’s participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.
Has the following relevant financial relationships:
Consultant or advisor for: Amgen; Bristol Myers Squibb Company; Celgene; Cellectis; GlaxoSmithKline; Janssen; Novartis; Takeda
Research funding from: CR Therapeutics; Janssen; Novartis; Takeda
Owns stock (publicly traded) in: TG Therapeutics
Other: Board of directors for: TG Therapeutics
Steering Committee Member
Has the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Agios; Astellas; Bristol Myers Squibb Company; Celgene; Cleave; Foghorn; Genentech; Genmab; Novartis; Notable Labs; Servier; Takeda
Received grants for clinical research from: AbbVie; Agios; Astex; Bristol Myers Squibb Company; Calithera; Celgene; Cleave; Foghorn; ImmuneOnc; Loxo
Steering Committee Member
Has the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Bayer; BeiGene; Celgene; Denovo; Epizyme; Janssen; Genentech; Genmab; Gilead; Karyopharm; Pharmacyclics; Roche; Seagen, Inc.; Spectrum
Received grants for clinical research from: 4D Pharma; AbbVie; Acerta; Adaptimmune; Allogene; Amgen; Bayer; Celgene; Cellectis; EMD Serono; Gilead; Genentech; Guardant; Iovance; Janssen; Kite; Morphosys; Nektar; Novartis; Pfizer; Pharmacyclics; Roche; Sanofi; Takeda; TG Therapeutics; Xencor; Ziopharm
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: Acrotech; C4 Therapeutics; Daiichi Sankyo; Janssen; Kura; KyowaHakko Kirin; Myeloid; ONO; Seagen, Inc.; SecuraBio; Shoreline; Takeda; Trillium; Tubulis; Yingli
Research funding from: ADC Therapeutics; Affimed; C4 Therapeutics; Celgene; Crispr; Daiichi Sankyo; KyowaHakko Kirin; Seagen, Inc.; SecuraBio; Takeda; Trillium; Verastem
Steering Committee Member
Has the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Amgen; Bristol Myers Squibb Company; Genentech; Novartis; Pfizer; Takeda
Received grants for clinical research from: AbbVie; Amgen; Pfizer; Takeda
Steering Committee Member
Has the following relevant financial relationships:
Consultant or advisor for: AbbVie; Amgen; Antengene; ArcellX; AstraZeneca; BeiGene; Bluebird; Bristol Myers Squibb Company; Epizyme; Genentech; Janssen; K36; Loxo; Monterosa; Oncopeptides; Roche; Sanofi; SecuraBio; Trillium
Research funding from: AbbVie; Amgen; Allogene; AstraZeneca; Bristol Myers Squibb Company; Carsgen; Genentech; GlaxoSmithKline; Janssen; Molecular Templates; Novartis; Regeneron; Roche; Takeda
Steering Committee Member
Has the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Amgen; AstraZeneca; Bristol Myers Squibb Company; Epizyme; Incyte; Pharmacyclics; Takeda
Steering Committee Member
The opinions expressed are those of Dr Maples and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Maples’s participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.
Has the following relevant financial relationships:
Served as an advisor or consultant for: GlaxoSmithKline (ended December 2021); Janssen (ended Oct 2021); Karyopharm (ended March 2021); Sanofi (ended Oct 2021)